Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies ; volume:22 ; number:1 ; day:2 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (2.7.2024), 1-14, 12.2024

Creator
Pu, Lian-Fang
Zheng, Hui-Min
Feng, Xiang-Jiang
Charwudzi, Alice
Liang, Xue
Hu, Lin-Hui
Ding, Yang-Yang
Liu, Ze-Lin
Liao, Ya
Xiong, Shu-Dao
Contributor
SpringerLink (Online service)

DOI
10.1186/s12967-024-05308-2
URN
urn:nbn:de:101:1-2409202139425.265819339939
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Pu, Lian-Fang
  • Zheng, Hui-Min
  • Feng, Xiang-Jiang
  • Charwudzi, Alice
  • Liang, Xue
  • Hu, Lin-Hui
  • Ding, Yang-Yang
  • Liu, Ze-Lin
  • Liao, Ya
  • Xiong, Shu-Dao
  • SpringerLink (Online service)

Other Objects (12)

MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy

MIP3α as an early prognostic predictor for patients with B-cell malignancies receiving CD19/CD22-redirected CAR-T cell cocktail therapy

CAR-T cell combination therapies in hematologic malignancies

CAR-T cell combination therapies in hematologic malignancies

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy

Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant

Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant

T cell senescence and CAR-T cell exhaustion in hematological malignancies

T cell senescence and CAR-T cell exhaustion in hematological malignancies

Special issue: CAR‐T cell therapy for hematological malignancies

Special issue: CAR‐T cell therapy for hematological malignancies

The Application of CAR-T Cells in Haematological Malignancies

The Application of CAR-T Cells in Haematological Malignancies

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells

Treatment of B cells malignancies with anti-CD19 CAR+, TCR-, CD52- allogeneic T cells

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies

Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T

Super-resolution microscopy reveals ultra-low CD19 expression on myeloma cells that triggers elimination by CD19 CAR-T

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy

Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapy

Related objects